These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20970032)

  • 1. A gene expression signature for chemoradiosensitivity of colorectal cancer cells.
    Spitzner M; Emons G; Kramer F; Gaedcke J; Rave-Fränk M; Scharf JG; Burfeind P; Becker H; Beissbarth T; Ghadimi BM; Ried T; Grade M
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1184-92. PubMed ID: 20970032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients.
    Agostini M; Zangrando A; Pastrello C; D'Angelo E; Romano G; Giovannoni R; Giordan M; Maretto I; Bedin C; Zanon C; Digito M; Esposito G; Mescoli C; Lavitrano M; Rizzolio F; Jurisica I; Giordano A; Pucciarelli S; Nitti D
    Cancer Biol Ther; 2015; 16(8):1160-71. PubMed ID: 26023803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.
    Grade M; Wolff HA; Gaedcke J; Ghadimi BM
    Langenbecks Arch Surg; 2012 Apr; 397(4):543-55. PubMed ID: 22382702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer.
    Gunderson LL; Nelson H; Martenson JA; Cha S; Haddock M; Devine R; Fieck JM; Wolff B; Dozois R; O'Connell MJ
    Dis Colon Rectum; 1996 Dec; 39(12):1379-95. PubMed ID: 8969664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g.
    Salendo J; Spitzner M; Kramer F; Zhang X; Jo P; Wolff HA; Kitz J; Kaulfuß S; Beißbarth T; Dobbelstein M; Ghadimi M; Grade M; Gaedcke J
    Radiother Oncol; 2013 Sep; 108(3):451-7. PubMed ID: 23932154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray Analysis of Long Non-coding RNA Expression Profile Associated with 5-Fluorouracil-Based Chemoradiation Resistance in Colorectal Cancer Cells.
    Xiong W; Jiang YX; Ai YQ; Liu S; Wu XR; Cui JG; Qin JY; Liu Y; Xia YX; Ju YH; He WJ; Wang Y; Li YF; Hou Y; Wang L; Li WH
    Asian Pac J Cancer Prev; 2015; 16(8):3395-402. PubMed ID: 25921151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial.
    Bujko K; Michalski W; Kepka L; Nowacki MP; Nasierowska-Guttmejer A; Tokar P; Dymecki D; Pawlak M; Lesniak T; Richter P; Wojnar A; Chmielik E;
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):369-77. PubMed ID: 17118570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor κ-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphy.
    O'Neil BH; Funkhouser WK; Calvo BF; Meyers MO; Kim HJ; Goldberg RM; Bernard SA; Caskey L; Deal AM; Wright F; Baldwin AS; Tepper JE
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):705-11. PubMed ID: 20630669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy.
    Kim JS; Kim JM; Li S; Yoon WH; Song KS; Kim KH; Yeo SG; Nam JS; Cho MJ
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):195-200. PubMed ID: 16839708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling.
    Folkvord S; Flatmark K; Dueland S; de Wijn R; Grøholt KK; Hole KH; Nesland JM; Ruijtenbeek R; Boender PJ; Johansen M; Giercksky KE; Ree AH
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):555-62. PubMed ID: 20675069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer.
    Esposito G; Pucciarelli S; Alaggio R; Giacomelli L; Marchiori E; Iaderosa GA; Friso ML; Toppan P; Chieco-Bianchi L; Lise M
    Ann Surg Oncol; 2001 May; 8(4):311-8. PubMed ID: 11352304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim DY; Jung KH; Kim TH; Kim DW; Chang HJ; Jeong JY; Kim YH; Son SH; Yun T; Hong CW; Sohn DK; Lim SB; Choi HS; Jeong SY; Park JG
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):378-84. PubMed ID: 17097835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.
    Moore HG; Shia J; Klimstra DS; Ruo L; Mazumdar M; Schwartz GK; Minsky BD; Saltz L; Guillem JG
    Ann Surg Oncol; 2004 Nov; 11(11):955-61. PubMed ID: 15525823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
    Unsal Kilic D; Uner A; Akyurek N; Erpolat P; Dursun A; Pak Y
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):196-203. PubMed ID: 17071013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.
    Ghadimi BM; Grade M; Difilippantonio MJ; Varma S; Simon R; Montagna C; Füzesi L; Langer C; Becker H; Liersch T; Ried T
    J Clin Oncol; 2005 Mar; 23(9):1826-38. PubMed ID: 15774776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of gene biomarkers to predict responses to neoadjuvant chemoradiotherapy in patients with rectal cancer and pathways enrichment analysis].
    Wang XJ; Yu Q; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1183-1187. PubMed ID: 31874536
    [No Abstract]   [Full Text] [Related]  

  • 17. X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients.
    Lamas MJ; Duran G; Gomez A; Balboa E; Anido U; Bernardez B; Rana-Diez P; Lopez R; Carracedo A; Barros F
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):138-44. PubMed ID: 21167658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
    Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
    Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
    Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
    Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications.
    Medich D; McGinty J; Parda D; Karlovits S; Davis C; Caushaj P; Lembersky B
    Dis Colon Rectum; 2001 Aug; 44(8):1123-8. PubMed ID: 11535851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.